The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirect Line Regulatory News (DLG)

Share Price Information for Direct Line (DLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 203.60
Bid: 203.60
Ask: 204.00
Change: 2.00 (0.99%)
Spread: 0.40 (0.196%)
Open: 201.20
High: 204.80
Low: 201.00
Prev. Close: 201.60
DLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Direct Line Insurance Group plc

26 Mar 2024 07:29

RNS Number : 3067I
Societe Generale SA
26 March 2024

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:

SOCIETE GENERALE SA

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Direct Line Insurance Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25/03/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes: Ageas SA/NV

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Ordinary 10 10/11p

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

28,757,171

2.19

42,960

0.00

(2) Cash-settled derivatives:

0

0.00

663,260

0.05

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

TOTAL:

28,757,171

2.19

706,220

0.05

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

EUR

Ordinary 10 10/11p

Purchase

1,000

2.25

Ordinary 10 10/11p

Sale

1,500

2.16

Class of relevant security

Purchase/sale

Number of securities

Price per unit

GBP

Ordinary 10 10/11p

Purchase

1,916

1.85415

Ordinary 10 10/11p

Purchase

2,573

1.89066

Ordinary 10 10/11p

Purchase

73

1.826

Ordinary 10 10/11p

Purchase

379

1.826

Ordinary 10 10/11p

Purchase

506

1.826

Ordinary 10 10/11p

Purchase

506

1.826

Ordinary 10 10/11p

Purchase

2,212

1.82

Ordinary 10 10/11p

Sale

560,531

1.854

Ordinary 10 10/11p

Sale

2,000

1.89638

Ordinary 10 10/11p

Sale

3,050

1.854

Ordinary 10 10/11p

Sale

4,875

1.854

Ordinary 10 10/11p

Sale

61,882

1.854

Ordinary 10 10/11p

Sale

2,370

1.84

Ordinary 10 10/11p

Sale

135

1.9015

Ordinary 10 10/11p

Sale

147

1.8985

Ordinary 10 10/11p

Sale

164

1.845

Ordinary 10 10/11p

Sale

208

1.9015

Ordinary 10 10/11p

Sale

306

1.8935

Ordinary 10 10/11p

Sale

499

1.895

Ordinary 10 10/11p

Sale

702

1.844

Ordinary 10 10/11p

Sale

744

1.896

Ordinary 10 10/11p

Sale

1,020

1.8985

Ordinary 10 10/11p

Sale

1,093

1.8985

Ordinary 10 10/11p

Sale

1,518

1.896

Ordinary 10 10/11p

Sale

1,624

1.844

Ordinary 10 10/11p

Sale

1,765

1.895

Ordinary 10 10/11p

Sale

1,838

1.8315

Ordinary 10 10/11p

Sale

1,913

1.9015

Ordinary 10 10/11p

Sale

1,960

1.8935

Ordinary 10 10/11p

Sale

2,263

1.8945

Ordinary 10 10/11p

Sale

2,263

1.8955

Ordinary 10 10/11p

Sale

2,263

1.896

Ordinary 10 10/11p

Sale

2,265

1.894

Ordinary 10 10/11p

Sale

2,267

1.8915

Ordinary 10 10/11p

Sale

2,325

1.8445

Ordinary 10 10/11p

Sale

2,350

1.825

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit GBP

Ordinary 10 10/11p

CFD

Increasing a short position

1,916

1.85415

Ordinary 10 10/11p

CFD

Increasing a short position

2,573

1.89066

Ordinary 10 10/11p

CFD

Reducing a short Position

560,531

1.854

Ordinary 10 10/11p

CFD

Reducing a short Position

2,000

1.89638

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

26/03/2024

Contact name:

Paul Jenkins

Telephone number:

+44 20 7676 6969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETSEMSWMELSEED
Date   Source Headline
30th Aug 20237:00 amRNSAppointment of CEO
28th Jul 20234:00 pmRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSResponse to press coverage
28th Jun 20232:00 pmRNSDirector/PDMR Shareholding
1st Jun 20235:00 pmRNSNotice of Results
31st May 20233:00 pmRNSDirector/PDMR Shareholding
30th May 20236:30 pmRNSDirector/PDMR Shareholding
30th May 20235:30 pmRNSDirector/PDMR Shareholding
12th May 20233:30 pmRNSDirector/PDMR Shareholding
9th May 20233:00 pmRNSResult of AGM
9th May 20237:00 amRNSTrading Update for Q1 2023
28th Apr 20233:00 pmRNSDirector/PDMR Shareholding
25th Apr 20235:00 pmRNSHolding(s) in Company
14th Apr 20234:00 pmRNSHolding(s) in Company
3rd Apr 20234:15 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:00 pmRNSNotice of 2023 AGM
31st Mar 20233:00 pmRNSHolding(s) in Company
31st Mar 20232:30 pmRNS2022 Solvency and Financial Condition Report
30th Mar 20233:00 pmRNSAppointment to Board Committees
28th Mar 20233:30 pmRNSDirector/PDMR Shareholding
28th Mar 20233:30 pmRNSDirector/PDMR Shareholding
24th Mar 20239:30 amRNS2022 Annual Report and Accounts
20th Mar 20234:00 pmRNSHolding(s) in Company
14th Mar 20236:30 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSPreliminary Results year ended 31 December 2022
10th Mar 202310:15 amRNSDirector Declaration
1st Mar 20235:00 pmRNSHolding(s) in Company
28th Feb 20234:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20236:15 pmRNSHolding(s) in Company
17th Feb 20237:00 amRNSDirectorate Change
15th Feb 20237:00 amRNSNotice of 2022 preliminary results
30th Jan 20233:00 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSDirectorate Change
26th Jan 20237:00 amRNSDirect Line Group executes strategic reinsurance
16th Jan 20236:00 pmRNSHolding(s) in Company
12th Jan 20233:00 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading Update
29th Dec 202212:00 pmRNSDirector/PDMR Shareholding
13th Dec 20224:00 pmRNSHolding(s) in Company
12th Dec 20227:00 amRNSIFRS 17 update
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
18th Nov 20224:00 pmRNSHolding(s) in Company
11th Nov 20223:00 pmRNSHolding(s) in Company
8th Nov 20227:00 amRNSTrading Update for Q3 2022
28th Oct 20225:30 pmRNSDirector/PDMR Shareholding
10th Oct 202211:30 amRNSChange of Auditor
28th Sep 20226:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20223:00 pmRNSDirector/PDMR Shareholding
13th Sep 20224:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.